Advanced search
Publication Cover
Expert Review of Hematology Volume 4, 2011 - Issue 1
Submit an article Journal homepage
74
Views
4
CrossRef citations to date
0
Altmetric
Perspective

Personalizing treatment for chronic lymphocytic leukemia

Pau Abrisqueta Department of Hematology, University Hospital of Vall d’Hebron 119–129, 08035 Barcelona, Spain; Department of Hematology, University Hospital of Vall d’Hebron 119–129, 08035 Barcelona, Spain
,
Marta Crespo Department of Hematology, University Hospital of Vall d’Hebron 119–129, 08035 Barcelona, Spain; Department of Hematology, University Hospital of Vall d’Hebron 119–129, 08035 Barcelona, Spain
&
Francesc Bosch Department of Hematology, University Hospital of Vall d’Hebron 119–129, 08035 Barcelona, Spain;[email protected]
Pages 27-35 | Published online: 10 Jan 2014

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Maliha Khan, Jamie L Gibbons & Alessandra Ferrajoli. (2017) Spotlight on ibrutinib and its potential in frontline treatment of chronic lymphocytic leukemia. OncoTargets and Therapy 10, pages 1909-1914.
Read now

Articles from other publishers (3)

Lesley J. Scott. (2019) Venetoclax: A Review in Relapsed/Refractory Chronic Lymphocytic Leukemia. Targeted Oncology 14:5, pages 493-504.
Crossref
Prabhjot KaurPrabhjot Kaur. 2018. Chronic Lymphocytic Leukemia. Chronic Lymphocytic Leukemia 61 89 .
MAŁGORZATA ROGALIŃSKA, JERZY Z. BŁOŃSKI, PAWEŁ GÓRALSKI, EWA WAWRZYNIAK, MARIUSZ HARTMAN, ANETA ROGALSKA, PAWEŁ ROBAK, ANETA KOCEVA-CHYŁA, HENRYK PIEKARSKI, TADEUSZ ROBAK & ZOFIA M. KILIAŃSKA. (2015) Relationship between in vitro drug sensitivity and clinical response of patients to treatment in chronic lymphocytic leukemia. International Journal of Oncology 46:3, pages 1259-1267.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.